Group One Trading’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $43.4M | Sell |
1,546,500
-2,009,800
| -57% | -$53.5M | 0.08% | 227 |
|
|
2025
Q4 | $88.6M | Buy |
3,556,300
+406,800
| +13% | +$10.3M | 0.15% | 116 |
|
|
2025
Q3 | $80.2M | Buy |
3,149,500
+500
| +0% | +$12.3K | 0.14% | 131 |
|
|
2025
Q2 | $76.3M | Sell |
3,149,000
-468,200
| -13% | -$10.9M | 0.17% | 89 |
|
|
2025
Q1 | $91.7M | Buy |
3,617,200
+61,900
| +2% | +$1.62M | 0.27% | 53 |
|
|
2024
Q4 | $94.3M | Buy |
3,555,300
+2,023,700
| +132% | +$54.9M | 0.22% | 62 |
|
|
2024
Q3 | $44.3M | Buy |
1,531,600
+419,300
| +38% | +$12.2M | 0.13% | 111 |
|
|
2024
Q2 | $31.1M | Buy |
1,112,300
+502,700
| +82% | +$13.8M | 0.12% | 124 |
|
|
2024
Q1 | $16.9M | Sell |
609,600
-97,300
| -14% | -$2.7M | 0.07% | 236 |
|
|
2023
Q4 | $20.4M | Buy |
706,900
+379,400
| +116% | +$11.5M | 0.05% | 340 |
|
|
2023
Q3 | $10.9M | Sell |
327,500
-7,300
| -2% | -$258K | 0.04% | 485 |
|
|
2023
Q2 | $12.3M | Sell |
334,800
-394,700
| -54% | -$15.4M | 0.04% | 420 |
|
|
2023
Q1 | $29.8M | Sell |
729,500
-2,352,500
| -76% | -$102M | 0.11% | 130 |
|
|
2022
Q4 | $158M | Sell |
3,082,000
-510,400
| -14% | -$24.5M | 0.37% | 30 |
|
|
2022
Q3 | $157M | Sell |
3,592,400
-258,700
| -7% | -$12.6M | 0.31% | 28 |
|
|
2022
Q2 | $202M | Sell |
3,851,100
-2,298,400
| -37% | -$117M | 0.32% | 30 |
|
|
2022
Q1 | $318M | Sell |
6,149,500
-1,360,300
| -18% | -$70.6M | 0.32% | 28 |
|
|
2021
Q4 | $443M | Sell |
7,509,800
-662,700
| -8% | -$32.8M | 0.36% | 27 |
|
|
2021
Q3 | $351M | Buy |
8,172,500
+5,366,200
| +191% | +$238M | 0.38% | 28 |
|
|
2021
Q2 | $110M | Sell |
2,806,300
-1,273,400
| -31% | -$49.5M | 0.13% | 102 |
|
|
2021
Q1 | $148M | Buy |
4,079,700
+10,600
| +0.3% | +$376K | 0.22% | 48 |
|
|
2020
Q4 | $150M | Buy |
4,069,100
+2,326,627
| +134% | +$85.3M | 0.26% | 37 |
|
|
2020
Q3 | $60.7M | Sell |
1,742,473
-99,919
| -5% | -$3.5M | 0.19% | 75 |
|
|
2020
Q2 | $57.2M | Buy |
1,842,392
+848,365
| +85% | +$28.8M | 0.26% | 53 |
|
|
2020
Q1 | $30.8M | Buy |
994,027
+409,373
| +70% | +$13.9M | 0.25% | 63 |
|
|
2019
Q4 | $21.7M | Sell |
584,654
-204,265
| -26% | -$7.28M | 0.15% | 129 |
|
|
2019
Q3 | $26.9M | Sell |
788,919
-125,110
| -14% | -$4.55M | 0.22% | 67 |
|
|
2019
Q2 | $37.6M | Buy |
914,029
+356,147
| +64% | +$14.1M | 0.34% | 31 |
|
|
2019
Q1 | $22.5M | Sell |
557,882
-456,593
| -45% | -$18.3M | 0.25% | 55 |
|
|
2018
Q4 | $42M | Sell |
1,014,475
-544,075
| -35% | -$22.6M | 0.36% | 38 |
|
|
2018
Q3 | $65.2M | Sell |
1,558,550
-325,897
| -17% | -$12.5M | 0.51% | 17 |
|
|
2018
Q2 | $64.9M | Buy |
1,884,447
+305,450
| +19% | +$10.4M | 0.55% | 11 |
|
|
2018
Q1 | $53.2M | Buy |
1,578,997
+396,514
| +34% | +$13.6M | 0.54% | 12 |
|
|
2017
Q4 | $40.6M | Buy |
1,182,483
+358,360
| +43% | +$12.2M | 0.29% | 53 |
|
|
2017
Q3 | $27.9M | Buy |
824,123
+483,470
| +142% | +$15.5M | 0.25% | 65 |
|
|
2017
Q2 | $10.9M | Sell |
340,653
-57,021
| -14% | -$1.8M | 0.11% | 196 |
|
|
2017
Q1 | $12.9M | Sell |
397,674
-17,391
| -4% | -$548K | 0.15% | 136 |
|
|
2016
Q4 | $12.8M | Sell |
415,065
-232,513
| -36% | -$7.1M | 0.12% | 170 |
|
|
2016
Q3 | $20.8M | Sell |
647,578
-175,596
| -21% | -$5.87M | 0.23% | 76 |
|
|
2016
Q2 | $27.5M | Buy |
823,174
+34,255
| +4% | +$1.09M | 0.33% | 48 |
|
|
2016
Q1 | $22.2M | Buy |
788,919
+401,890
| +104% | +$11.5M | 0.31% | 42 |
|
|
2015
Q4 | $11.9M | Sell |
387,029
-208,270
| -35% | -$6.55M | 0.14% | 130 |
|
|
2015
Q3 | $17.7M | Buy |
595,299
+481,678
| +424% | +$15.4M | 0.25% | 55 |
|
|
2015
Q2 | $3.62M | Buy |
113,621
+112,778
| +13,378% | +$3.68M | 0.05% | 448 |
|
|
2015
Q1 | $28K | Buy |
+843
| New | +$26.8K | ﹤0.01% | 3715 |
|
Other funds holding PFE
VCM
VPM
Group One Trading's PFE Position: Q1 2026 in Review
Group One Trading increased its Pfizer (PFE) stake by 271% in Q1 2026, buying an estimated $11.5M and bringing the position to 592,233 shares worth $16.6M. The position accounts for 0.03% of the portfolio, ranked #579.
Group One Trading first reported a position in PFE in Q4 2014 and has held it in 32 quarters since. The position peaked at $32.9M in Q2 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Group One Trading held 592,233 shares of Pfizer worth $16.6M as of Q1 2026.
- Group One Trading bought 432,806 Pfizer shares in Q1 2026, an estimated $11.5M.
- Pfizer made up 0.03% of Group One Trading's portfolio in Q1 2026, its #579 holding.
- Group One Trading first reported a position in Pfizer in Q4 2014 and has held it in 32 quarters since.
- Group One Trading's Pfizer position peaked at $32.9M in Q2 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.